^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SYHA1813
i
Other names: SYHA1813
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CSPC Pharma, Shanghai Inst. of Materia Medica
Drug class:
VEGFR inhibitor, CSF-1R inhibitor
Related drugs:
